What patients with gilles de la tourette syndrome should be treated with deep brain stimulation and what is the best target?

Neurosurgery

Volumn 71, Issue 1, 2012, Pages 173-192

  Piedad, John Carlo Pansaon ^a   Rickards, Hugh Edward ^a   Cavanna, Andrea Eugenio ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Basal ganglia; Behavior; Deep brain stimulation; Gilles de la Tourette syndrome; Thalamus; Tics

Indexed keywords

BOTULINUM TOXIN; CLONIDINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; GUANFACINE; HALOPERIDOL; OLANZAPINE; PIMOZIDE; RISPERIDONE; SEROTONIN; TETRABENAZINE;

AGE DISTRIBUTION; ANXIETY; AUTOIMMUNITY; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BRAIN DAMAGE; BRAIN DEPTH STIMULATION; CAPSULA INTERNA; CAUDATE NUCLEUS; CEREBELLUM; COMORBIDITY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DYSARTHRIA; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FRONTAL CORTEX; GILLES DE LA TOURETTE SYNDROME; GLOBUS PALLIDUS; HEADACHE; HEMATOMA; HEREDITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LETHARGY; LIMBIC SYSTEM; MUSCLE HYPERTONIA; MUSCLE HYPOTONIA; MUTISM; NAUSEA; NEUROIMAGING; NUCLEUS ACCUMBENS; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PARESTHESIA; PARKINSONISM; PATHOPHYSIOLOGY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PSYCHOGENESIS; REVIEW; SEDATION; SEROTONINERGIC SYSTEM; SEXUAL DYSFUNCTION; SIDE EFFECT; SYNCOPE; SYSTEMATIC REVIEW; THALAMUS; TIC; TREATMENT OUTCOME; VERTIGO; WEIGHT GAIN;

AGE OF ONSET; BRAIN; DATABASES, BIBLIOGRAPHIC; DEEP BRAIN STIMULATION; HUMANS; TOURETTE SYNDROME;

EID: 84862850661     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e3182535a00     Document Type: Review

References (136)

1. World Health Organisation. ICD-1 Classification Mental Behavioural Disorders Clinical Descriptions Diagnostic Guidelines. Geneva, Switzerland: World Health Organisation; 1992.
2. The Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders. Arch Neurol. 1993;50(10):1013-1016.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
4. Robertson MM. Tourette syndrome, associated conditions and the complexities of treatment. Brain. 2000;123(pt 3):425-462. (Pubitemid 30099531)
5. Leckman JF. Tourette's syndrome. Lancet. 2002;360(9345):1577-1586. (Pubitemid 35356375)
6. Kwak C, Dat Vuong K, Jankovic J. Premonitory sensory phenomenon in Tourette's syndrome. Mov Disord. 2003;18(12):1530-1533. (Pubitemid 38035379)
7. Leckman JF, Zhang H, Vitale A, et al. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics. 1998;102(1 pt 1):14-19. (Pubitemid 28309239)
8. Ohm B. The effect of Tourette syndrome on the education and social interactions of a school-age child. J Neurosci Nurs. 2006;38(3):194-195.
9. Bajwa RJ, de Lotbinière AJ, King RA, et al. Deep brain stimulation in Tourette's syndrome. Mov Disord. 2007;22(9):1346-1350. (Pubitemid 47325049)
10. Servello D, Sassi M, Brambilla A, Defendi S, Porta M. Long-term, post-deep brain stimulation management of a series of 36 patients affected with refractory Gilles de la Tourette syndrome. Neuromodulation. 2010;13(3):187-194.
11. Cooper C, Robertson MM, Livingston G. Psychological morbidity and caregiver burden in parents of children with Tourette's disorder and psychiatric comorbidity. J Am Acad Child Adolesc Psychiatry. 2003;42(11):1370-1375. (Pubitemid 39585998)
12. Robertson MM. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res. 2008;65(5):461-472.
13. Bloch MH, Leckman JF. Clinical course of Tourette syndrome. J Psychosom Res. 2009;67(6):497-501.
14. Pappert EJ, Goetz CG, Louis ED, Blasucci L, Leurgans S. Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome. Neurology. 2003;61 (7):936-940. (Pubitemid 37248648)
15. Cavanna AE, Servo S, Monaco F, Robertson MM. The behavioral spectrum of Gilles de la Tourette syndrome. J Neuropsychiatry Clin Neurosci. 2009;21(1): 13-23.
16. Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol. 2000;42(7): 436-447. (Pubitemid 30427051)
17. Freeman RD; Tourette Syndrome International Database Consortium. Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome. Eur Child Adolesc Psychiatry. 2007;16(suppl 1):15-23.
18. Leckman JF, Bloch MH, Scahill L, King RA. Tourette syndrome: the self under siege. J Child Neurol. 2006;21(8):642-649. (Pubitemid 44295122)
19. Eddy CM, Rizzo R, Gulisano M, et al. Quality of life in young people with Tourette syndrome: a controlled study. J Neurol. 2011;258(2):291-301.
20. Cavanna AE, Schrag A, Morley D, et al. The Gilles de la Tourette syndromequality of life scale (GTS-QOL): development and validation. Neurology. 2008; 71(18):1410-1416.
21. Eapen V, Crncec R. Tourette syndrome in children and adolescents: special considerations. J Psychosom Res. 2009;67(6):525-532.
22. Mukhida K, Bishop M, Hong M, Mendez I. Neurosurgical strategies for Gilles de la Tourette's syndrome. Neuropsychiatr Dis Treat. 2008;4(6):1111-1128.
23. O'Rourke JA, Scharf JM, Yu D, Pauls DL. The genetics of Tourette syndrome: a review. J Psychosom Res. 2009;67(6):533-545.
24. Martino D, Dale RC, Gilbert DL, Giovannoni G, Leckman JF. Immunopathogenic mechanisms in Tourette syndrome: a critical review. Mov Disord. 2009;24 (9):1267-1279.
25. Martino D, Defazio G, Giovannoni G. The PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorder. J Psychosom Res. 2009;67(6): 547-557.
26. Steeves TD, Fox SH. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome. Prog Brain Res. 2008;172: 495-513.
27. Plessen KJ, Bansal R, Peterson BS. Imaging evidence for anatomical disturbances and neuroplastic compensation in persons with Tourette syndrome. J Psychosom Res. 2009;67(6):559-573.
28. Rickards H. Functional neuroimaging in Tourette syndrome. J Psychosom Res. 2009;67(6):575-584.
29. Stern E, Silbersweig DA, Chee KY. A functional neuroanatomy of tics in Tourette syndrome. Arch Gen Psychiatry. 2000;57(8):741-748. (Pubitemid 30650108)
30. Peterson BS, Staib L, Scahill L, et al. Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry. 2001;58(5):427-440. (Pubitemid 32411322)
31. Sowell ER, Kan E, Yoshii J, et al. Thinning of sensorimotor cortices in children with Tourette syndrome. Nat Neurosci. 2008;11(6):637-639. (Pubitemid 351748118)
32. Steeves TD, Ko JH, Kideckel DM, et al. Extrastriatal dopaminergic dysfunction in Tourette syndrome. Ann Neurol. 2010;67(2):170-181.
33. Peterson BS, Skudlarski P, Anderson AW, et al. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch Gen Psychiatry. 1998;55(4):326-333. (Pubitemid 28173622)
34. Peterson BS, Thomas P, Kane MJ, et al. Basal ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry. 2003;60(4):415-424. (Pubitemid 36403003)
35. Visser-Vandewalle V. DBS in Tourette syndrome: rationale, current status and future prospects. Acta Neurochir Suppl. 2007;97(pt 2):215-222.
36. Rickards H, Hartley N, Robertson MM. Seignot's paper on the treatment of Tourette's syndrome with haloperidol. Classic Text No. 31. Hist Psychiatry. 1997;8(31 pt 3):433-436. (Pubitemid 127501105)
37. Shapiro AK, Shapiro E. Treatment of Gilles de la Tourette's syndrome with haloperidol. Br J Psychiatry. 1968;114(508):345-350.
38. Singer HS, Butler IJ, Tune LE, Seifert WE Jr, Coyle JT. Dopaminergic dysfunction in Tourette syndrome. Ann Neurol. 1982;12(4):361-366. (Pubitemid 12024354)
39. Onofrj M, Paci C, D'Andreamatteo G, Toma L. Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs. low-dose pimozide. J Neurol. 2000;247(6):443-446. (Pubitemid 30433558)
40. Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS. A placebocontrolled trial of risperidone in Tourette syndrome. Neurology. 2003;60(7): 1130-1135. (Pubitemid 36418773)
41. Porta M, Sassi M, Cavallazzi M, Fornari M, Brambilla A, Servello D. Tourette's syndrome and role of tetrabenazine: review and personal experience. Clin Drug Investig. 2008;28(7):443-459. (Pubitemid 351821482)
42. Pringsheim T, Marras C. Pimozide for tics in Tourette's syndrome. Cochrane Database Syst Rev. 2009;(2):CD006996.
43. Singer HS, Szymanski S, Giuliano J, et al. Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. Am J Psychiatry. 2002;159(8): 1329-1336. (Pubitemid 34832714)
44. Wong DF, Brašić JR, Singer HS, et al. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology. 2008;33(6): 1239-1251. (Pubitemid 351521728)
45. Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ. Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry. 1991;48(4): 324-328.
46. Eddy CM, Rickards HE, Cavanna AE. Treatment strategies for tics in Tourette syndrome. Ther Adv Neurol Disord. 2011;4(1):25-45.
47. Marras C, Andrews D, Sime E, Lang AE. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology. 2001;56(5): 605-610. (Pubitemid 32209992)
48. Porta M, Maggioni G, Ottaviani F, Schindler A. Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A. Neurol Sci. 2004;24(6):420-423. (Pubitemid 38256251)
49. Azrin NH, Nunn RG. Habit-reversal: a method of eliminating nervous habits and tics. Behav Res Ther. 1973;11(4):619-628.
50. Piacentini J, Woods DW, Scahill L, et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010;303(19): 1929-1937.
51. Hoogduin K, Verdellen C, Cath D. Exposure and response prevention in the treatment of Gilles de la Tourette's syndrome: four case studies. Clin Psychol Psychother. 1997;4(2):125-135. (Pubitemid 127493989)
52. Verdellen CW, Hoogduin CA, Keijsers GP. Tic suppression in the treatment of Tourette's syndrome with exposure therapy: the rebound phenomenon reconsidered. Mov Disord. 2007;22(11):1601-1606. (Pubitemid 47477922)
53. Verdellen CW, Keijsers GP, Cath DC, Hoogduin CA. Exposure with response prevention versus habit reversal in Tourette's syndrome: a controlled study. Behav Res Ther. 2004;42(5):501-511. (Pubitemid 38368901)
54. Bloch MH, Leckman JF. Clinical course of Tourette syndrome. J Psychosom Res. 2009;67(6):497-501.
55. Temel Y, Visser-Vandewalle V. Surgery in Tourette syndrome. Mov Disord. 2004;19(1):3-14. (Pubitemid 38559615)
56. Erenberg G, Cruse RP, Rothner AD. The natural history of Tourette syndrome: a follow-up study. Ann Neurol. 1987;22(3):383-385. (Pubitemid 17137903)
57. Chappell PB, Leckman JF, Riddle MA. The pharmacologic treatment of tic disorders. Child Adolesc Psychiatr Clin N Am. 1995;4:197-216.
58. Sallee FR, Nesbitt L, Jackson C, Sine L, Sethuraman G. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am J Psychiatry. 1997;154(8):1057-1062. (Pubitemid 27328819)
59. Ackermans L, Temel Y, Visser-Vandewalle V. Deep brain stimulation Tourette's syndrome. In: Tarsy D, Vitek JL, Starr PA, Okun M, eds. Deep Brain Stimulation in Neurological and Psychiatric Disorders. Totowa, NJ: Humana Press; 2009: 321-332.
60. Benabid AL, Wallace B, Mitrofanis J, et al. A putative generalized model of the effects and mechanism of action of high frequency electrical stimulation of the central nervous system. Acta Neurol Belg. 2005;105 (3):149-157. (Pubitemid 41479700)
61. Kringelbach ML, Jenkinson N, Owen SL, Aziz TZ. Translational principles of deep brain stimulation. Nat Rev Neurosci. 2007;8(8):623-635. (Pubitemid 47093935)
62. National Institute For Health and Clinical Excellence. Deep Brain Stimulation for Parkinson's Disease. London, UK: National Institute for Health and Clinical Excellence; 2003. Available at: http://www.nice.org.uk/nicemedia/ pdf/ip/ IPG019guidance.pdf. Accessed January 31, 2010.
63. National Institute For Health and Clinical Excellence. Deep Brain Stimulation for Tremor and Dystonia (Excluding Parkinson's Disease). London, UK: National Institute for Health and Clinical Excellence; 2006. Available at: http://www.nice.org.uk/nicemedia/pdf/ip/IPG188guidance.pdf. Accessed January 31. 2010.
64. Awan NR, Lozano A, Hamani C. Deep brain stimulation: current and future perspectives. Neurosurg Focus. 2009;27(1):E2.
65. Vandewalle V, van der Linden C, Groenewegen HJ, Caemaert J. Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet. 1999;353(9154):724. (Pubitemid 29103812)
66. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
67. Mink JW, Walkup J, Frey KA, et al. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord. 2006;21(11):1831-1838. (Pubitemid 44848927)
68. Porta M, Servello D, Sassi M, et al. Issues related to deep brain stimulation for treatment-refractory Tourette's syndrome. Eur Neurol. 2009;62(5):264-273.
69. Ackermans L, Temel Y, Visser-Vandewalle V. Deep brain stimulation in Tourette's syndrome. Neurotherapeutics. 2008;5(2):339-344. (Pubitemid 351446214)
70. Pringsheim T, Lang A, Kurlan R, Pearce M, Sandor P. Understanding disability in Tourette syndrome. Dev Med Child Neurol. 2009;51(6):468-472.
71. Poysky J, Jimenez-Shahed J. Reply: patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord. 2007; 22(9):1366-1367. (Pubitemid 47325059)
72. Maciunas RJ,Maddux BN, Riley DE, et al. Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome. J Neurosurg. 2007;107(5):1004-1014. (Pubitemid 350255216)
73. Welter ML, Mallet L, Houeto JL, et al. Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Arch Neurol. 2008;65(7):952-957. (Pubitemid 352008480)
74. Cavanna AE, Eddy CM, Mitchell R, et al. An approach to deep brain stimulation for severe treatment-refractory Tourette syndrome: the UK perspective. Br J Neurosurg. 2011;25(1):38-44.
75. Shahed J, Poysky J, Kenney C, Simpson R, Jankovic J. GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbidities. Neurology. 2007;68(2):159-160. (Pubitemid 46071905)
76. Dueck A, Wolters A, Wunsch K, et al. Deep brain stimulation of globus pallidus internus in a 16-year-old boy with severe Tourette syndrome and mental retardation. Neuropediatrics. 2009;40(5):239-242.
77. Servello D, Porta M, Sassi M, Brambilla A, Robertson MM. Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry. 2008;79 (2):136-142. (Pubitemid 351236542)
78. Mink JW. Reply: patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord. 2007;22(9):1367-1368. (Pubitemid 47325060)
79. Okun MS, Fernandez HH, Foote KD, Murphy TK, Goodman WK. Avoiding deep brain stimulation failures in Tourette syndrome. J Neurol Neurosurg Psychiatry. 2008;79(2):111-112. (Pubitemid 351236534)
80. Benabid AL, Vhabardes S, Seigneuret E, Torres N. Future aspects of neuromodulation: from treatment to enhancement? Neuromodulation. 2007; 10:185-186. (Pubitemid 46496737)
81. Visser-Vandewalle V, Temel Y, Boon P, et al. Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg. 2003;99(6):1094-1100. (Pubitemid 44717410)
82. Ackermans L, Duits A, Temel Y, et al. Long-term outcome of thalamic deep brain stimulation in two patients with Tourette syndrome. J Neurol Neurosurg Psychiatry. 2010;81(10):1068-1072.
83. van der Linden C, Colle H, Vandewalle V, Alessi G, Rijckaert D, De Waele L. Successful treatment of tics with bilateral internal pallidum (GPi) stimulation in a 27-year-old male patient with Gilles de la Tourette's syndrome (GTS). Mov Disord. 2002;17(suppl 5):S341.
84. Ackermans L, Temel Y, Cath D, et al. Deep brain stimulation in Tourette's syndrome: two targets? Mov Disord. 2006;21(5):709-713. (Pubitemid 43792758)
85. Visser-Vandewalle V. On the edge between movement disorder surgery and psychosurgery: guidelines for deep brain stimulation in Tourette syndrome. Neuromodulation. 2007;10:182-183. (Pubitemid 46496733)
86. Janik P, Hoziara H, Mandat T. Deep brain stimulation of CM-Spv-Voi complex for alleviating symptoms of Tourette syndrome. Parkinsonism Relat Disord. 2007; 15(suppl 2):S30.
87. Ackermans L, Duits A, van der Linden C, et al. Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome. Brain. 2011;134(pt 3): 832-844.
88. Shields DC, Cheng ML, Flaherty AW, Gale JT, Eskandar EN. Microelectrode-guided deep brain stimulation for Tourette syndrome: within-subject comparison of different stimulation sites. Stereotact Funct Neurosurg. 2008;86(2):87-91. (Pubitemid 351341534)
89. Priori A, Cogiamanian F, Mrakic-Sposta S, et al. Deep brain stimulation of the centromedian nucleus for the treatment of Tourette syndrome: a case report. J Neurol Sci. 2005;238(suppl 1):S326-S327.
90. Egidi M, Carrabba G, Priori A, et al. Thalamic DBS in Tourette syndrome: case report. In: Proceedings of the 14th Meeting of the World Society for Stereotactic and Functional Neurosurgery, Rome, Italy, 14-17 June 2005. International Functional Electrical Stimulation Society, Inc: http://www.ifess.org/INS-WSSFN-2005/ WSSFN/ABSTRACT/369.pdf. Accessed February 19, 2010.
91. Houeto JL, Karachi C, Mallet L, et al. Tourette's syndrome and deep brain stimulation. J Neurol Neurosurg Psychiatry. 2005;76(7):992-995. (Pubitemid 40909560)
92. Plewnia C, Rzensnitzek L, Schober F, et al. Deep brain stimulation of the thalamus as a treatment of intractable Tourette syndrome. Clin Neurophysiol. 2009;120:E72.
93. Maddux BN, Riley DE, Whitney CM, Maciunas RJ. Clinical efficacy and video analysis of deep brain stimulation for medically intractable Tourette syndrome. Mov Disord. 2004;19(9):1123.
94. Porta M, Brambilla A, Cavanna AE, et al. Thalamic deep brain stimulation for treatment-refractory Tourette syndrome: two-year outcome. Neurology. 2009;73 (17):1375-1380.
95. Resnick AS, Sassi M, Porta M, et al. Need for bilateral thalamic deep brain stimulation (DBS) to address unsuccessful single-sided procedure for Tourette syndrome: a case report. Mov Disord. 2010;25(suppl 2):S465.
96. Marceglia S, Servello D, Foffani G, et al. Thalamic single-unit and local field potential activity in Tourette syndrome. Mov Disord. 2010;25(3): 300-308.
97. Idris Z, Ghani AR, Mar W, et al. Intracerebral haematomas after deep brain stimulation surgery in a patient with Tourette syndrome and low factor XIIIA activity. J Clin Neurosci. 2010;17(10):1343-1344.
98. Vernaleken I, Kuhn J, Lenartz D, et al. Bithalamical deep brain stimulation in Tourette syndrome is associated with reduction in dopaminergic transmission. Biol Psychiatry. 2009;66(10):e15-e17.
99. Vernaleken I, Kuhn J, Janouschek H, et al. Acute and chronic effects of bithalamic deep brain stimulation on dopaminergic transmission. NeuroImage. 2010;52(suppl 1):S103.
100. Diederich NJ, Kalteis K, Stamenkovic M, Pieri V, Alesch F. Efficient internal pallidal stimulation in Gilles de la Tourette syndrome: a case report. Mov Disord. 2005;20(11):1496-1499. (Pubitemid 43072659)
101. Dehning S, Mehrkens JH, Müller N, Bötzel K. Therapy-refractory Tourette syndrome: beneficial outcome with globus pallidus internus deep brain stimulation. Mov Disord. 2008;23(9):1300-1302.
102. Foltynie T, Martinez-Torres I, Zrinzo L, et al. Improvement in vocal and motor tics following DBS of motor GPi for Tourette syndrome, not accompanied by subjective improvement in quality of life - a case report. Mov Disord. 2009;24 (suppl 1):S497-S498.
103. Gallagher CL, Garell PC, Montgomery EB Jr. Hemi tics and deep brain stimulation. Neurology. 2006;66(3):E12. (Pubitemid 43739922)
104. Kuhn J, Lenartz D, Mai JK, et al. Deep brain stimulation of the nucleus accumbens and the internal capsule in therapeutically refractory Tourettesyndrome. J Neurol. 2007;254(7):963-965. (Pubitemid 47222295)
105. Kuhn J, Lenartz D, Huff W, et al. Transient manic-like episode following bilateral deep brain stimulation of the nucleus accumbens and the internal capsule in a patient with Tourette syndrome. Neuromodulation. 2008;11(2): 128-131. (Pubitemid 351490216)
106. Neuner I, Podoll K, Lenartz D, Sturm V, Schneider F. Deep brain stimulation in the nucleus accumbens for intractable Tourette's syndrome: follow-up report of 36 months. Biol Psychiatry. 2009;65(4):e5-e6.
107. Servello D, Sassi M, Brambilla A, et al. De novo and rescue DBS leads for refractory Tourette syndrome patients with severe comorbid OCD: a multiple case report. J Neurol. 2009;256:1533-1539.
108. Flaherty AW, Williams ZM, Amirnovin R, et al. Deep brain stimulation of the anterior internal capsule for the treatment of Tourette syndrome: technical case report. Neurosurgery. 2005;57(4 suppl):E403.
109. Zabek M, Sobstyl M, Koziara H, Dzierzecki S. Deep brain stimulation of the right nucleus accumbens in a patient with Tourette syndrome. Case report. Neurol Neurochir Pol. 2008;42(6):554-559.
110. Burdick A, Foote KD, Goodman W, et al. Lack of benefit of accumbens/capsular deep brain stimulation in a patient with both tics and obsessive-compulsive disorder. Neurocase. 2010;16(4):321-330.
111. Martinez-Torres I, Hariz MI, Zrinzo L, Foltynie T, Limousin P. Improvement of tics after subthalamic nucleus deep brain stimulation. Neurology. 2009;72(20): 1787-1789.
112. Kuhn J, Lenartz D, Heuckmann J, Huff W, Klosterkötter J, Sturm V. Deep brain stimulation of different anatomic structures in therapeutically refractory Tourette syndrome. Clin Neurophysiol. 2009;120:E81-E82.
113. Neuner I, Halfter S, Wollenweber F, Podoll K, Schneider F. Nucleus accumbens deep brain stimulation did not prevent suicide attempt in Tourette syndrome. Biol Psychiatry. 2010;68(4):e19-e20.
114. Goethals I, Jacobs F, Van der Linden C, Caemaert J, Audenaert K. Brain activation associated with deep brain stimulation causing dissociation in a patient with Tourette's syndrome. J Trauma Dissociation. 2008;9(4):543-549.
115. Schoenberg M, Ogrocki P, Maddux B, et al. Bilateral thalamic DBS for the treatment of refractory Tourette's syndrome. Arch Clin Neuropsychol. 2010; 24:432.
116. Ackermans L, Temel Y, Bauer NJ, Visser-Vandewalle V. Vertical gaze palsy after thalamic stimulation for Tourette syndrome: case report. Neurosurgery. 2007;61 (5):E1100. (Pubitemid 350306984)
117. Servello D, Sassi M, Gaeta M, Ricci C, Porta M. Tourette Syndrome (TS) bears a higher rate of complications at the implanted hardware in deep brain stimulation (DBS). Acta Neurochir (Wien). 2011;153(3):629-632.
118. Hassler R, Dieckmann G. Traitment stéréotaxique des tics et cris inarticulés ou coprolaliques considérés comme phenomena d'obsession motrice au cours de la maladie de Gilles de la Tourette [in French]. Rev Neurol (Paris). 1970;123(2): 89-100.
119. Rickards H, Wood C, Cavanna AE. Hassler and Dieckmann's seminal paper on stereotactic thalamotomy for Gilles de la Tourette syndrome: translation and critical reappraisal. Mov Disord. 2008;23(14):1966-1972.
120. François C, Grabli D, McCairn K, et al. Behavioural disorders induced by external globus pallidus dysfunction in primates II. Anatomical study. Brain. 2004;127(pt 9):2055-2070. (Pubitemid 39150263)
121. Nuttin B, Cosyns P, Demeulemeester H, Gybels J, Meyerson B. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet. 1999;354(9189):1526. (Pubitemid 29502111)
122. Okun MS, Bowers D, Springer U, et al. What's in a "smile"? Intra-operative observations of contralateral smiles induced by deep brain stimulation. Neurocase. 2004;10(4):271-279. (Pubitemid 39585766)
123. Okun MS, Mann G, Foote KD, et al. Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming. J Neurol Neurosurg Psychiatry. 2007;78(3):310-314. (Pubitemid 46579673)
124. Van der Werf YD, Witter MP, Groenewegen HJ. The intralaminar and midline thalamic nuclei. Anatomical and functional evidence for participation in processes of arousal and awareness. Brain Res Brain Res Rev. 2002;39(2-3):107-140. (Pubitemid 35341095)
125. Benarroch EE. The midline and intralaminar thalamic nuclei: anatomic and functional specificity and implications in neurologic disease. Neurology. 2008;71 (12):944-949.
126. Goetz CG, Leurgans S, Chmura TA. Home alone: methods to maximize tic expression for objective videotape assessments in Gilles de la Tourette syndrome. Mov Disord. 2001;16(4):693-697. (Pubitemid 36040849)
127. Sudhyadhom A, Bova FJ, Foote KD, Rosado CA, Kirsch-Darrow L, Okun MS. Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications. Curr Neurol Neurosci Rep. 2007;7(4): 278-289. (Pubitemid 47098449)
128. Steigerwald F, Volkmann J. Intra-operative microrecording and stimulation. In Tarsy D, Vitek JL, Starr PA, Okun M, eds. Deep Brain Stimulation in Neurological and Psychiatric Disorders. Totowa, NJ: Humana Press; 2008: 111-134.
129. Hariz MI, Robertson MM. Gilles de la Tourette syndrome and deep brain stimulation. Eur J Neurosci. 2010;32(7):1128-1134.
130. Servello D, Sassi M, Defendi S, Brambilla A, Porta M. Pitfalls in deep brain stimulation for treatment-refractory Tourette syndrome. Mov Disord. 2010;25 (suppl 2):S529.
131. Müller-Vahl KR, Cath DC, Cavanna AE, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation. Eur Child Adolesc Psychiatry. 2011;20(4):209-217.
132. Mink JW. Clinical review of DBS for Tourette syndrome. Front Biosci (Elite Ed). 2009;1:72-76.
133. Leckman JF, Riddle MA, Hardin MT, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28(4):566-573. (Pubitemid 19196295)
134. Goetz CG, Tanner CM, Wilson RS, Shannon KM. A rating scale for Gilles de la Tourette's syndrome: description, reliability, and validity data. Neurology. 1987; 37(9):1542-1544. (Pubitemid 17132341)
135. Goetz CG, Pappert EJ, Louis ED, Raman R, Leurgans S. Advantages of a modified scoring method for the Rush Video-Based Tic Rating Scale. Mov Disord. 1999;14(3):502-506. (Pubitemid 30011665)
136. French J, Gronseth G. Lost in a jungle of evidence: we need a compass. Neurology. 2008;71(20):1634-1638.